Literature DB >> 26052771

Response to Magro et al.

James Irwin1, Graham Radford-Smith2.   

Abstract

Mesh：

Year:  2015        PMID： 26052771     DOI： 10.1038/ajg.2015.131

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  15 in total

1.  A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

Authors:  B G Feagan; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; J Koval; C J Wong; M Hopkins; S B Hanauer; J W McDonald
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

2.  Is it possible to change phenotype progression in Crohn's disease in the era of immunomodulators? Predictive factors of phenotype progression.

Authors:  Fernando Magro; Eduardo Rodrigues-Pinto; Rosa Coelho; Patrícia Andrade; João Santos-Antunes; Susana Lopes; Claudia Camila-Dias; Guilherme Macedo
Journal:  Am J Gastroenterol       Date:  2014-05-06       Impact factor: 10.864

3.  Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

Authors:  Jean-Frédéric Colombel; William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Remo Panaccione; Stefan Schreiber; Dan Byczkowski; Ju Li; Jeffrey D Kent; Paul F Pollack
Journal:  Gastroenterology       Date:  2006-11-29       Impact factor: 22.682

4.  Infliximab, azathioprine, or combination therapy for Crohn's disease.

Authors:  Jean Frédéric Colombel; William J Sandborn; Walter Reinisch; Gerassimos J Mantzaris; Asher Kornbluth; Daniel Rachmilewitz; Simon Lichtiger; Geert D'Haens; Robert H Diamond; Delma L Broussard; Kezhen L Tang; C Janneke van der Woude; Paul Rutgeerts
Journal:  N Engl J Med       Date:  2010-04-15       Impact factor: 91.245

Review 5.  Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease.

Authors:  W Sandborn; L Sutherland; D Pearson; G May; R Modigliani; C Prantera
Journal:  Cochrane Database Syst Rev       Date:  2000

Review 6.  Azathioprine for maintaining remission of Crohn's disease.

Authors:  D C Pearson; G R May; G Fick; L R Sutherland
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.

Authors:  J Cosnes; I Nion-Larmurier; L Beaugerie; P Afchain; E Tiret; J-P Gendre
Journal:  Gut       Date:  2005-02       Impact factor: 23.059

8.  Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators.

Authors:  B G Feagan; J Rochon; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; R Gillies; M Hopkins
Journal:  N Engl J Med       Date:  1995-02-02       Impact factor: 91.245

Review 9.  Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.

Authors:  Eliza Prefontaine; Lloyd R Sutherland; John K Macdonald; Monica Cepoiu
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

10.  The impact of timing and duration of thiopurine treatment on first intestinal resection in Crohn's disease: national UK population-based study 1989-2010.

Authors:  Sukhdev Chatu; Sonia Saxena; Venkataraman Subramanian; Vasa Curcin; Ghasem Yadegarfar; Laura Gunn; Azeem Majeed; Richard C G Pollok
Journal:  Am J Gastroenterol       Date:  2014-01-28       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.